Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.
about
Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysisAntidepressants, anxiolytics, and hypnotics in pregnancy and lactationCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyondModulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalitiesAntidepressant use in pregnancy: a critical review focused on risks and controversiesFetal effects of psychoactive drugsPregnancy exposure to serotonin reuptake inhibitors and the risk of spontaneous abortions.Continuing medical education: SSRIs and pregnancy.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesThe safety of antidepressant drugs during pregnancy.Selective serotonin reuptake inhibitor discontinuation during pregnancy: at what risk?Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programmingSelective serotonin reuptake inhibitors affect neurobehavioral development in the human fetusSelective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?Perinatal depression: treatment options and dilemmas.Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study.The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspringTreatment of perinatal mood and anxiety disorders: a review.Use of selective serotonin-reuptake inhibitors in the first trimester and risk of cardiovascular-related malformations: a meta-analysis of cohort studies.Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations.Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.Pregnancy, depression, antidepressants and breast-feeding.Management of prescription and nonprescription drug use during pregnancy.Factors impacting decisions to decline or adhere to antidepressant medication in perinatal women with mood and anxiety disorders.Teratology: more than malformations.
P2860
Q21198704-A439D9B8-325A-4513-85AB-D0FA51988AB6Q26795384-3B8CA439-532A-4468-ADC5-D4F7F1752E18Q27009995-82392958-DB2C-4F5C-B5C2-7BEFD5950EE5Q27010327-251E48B5-CAC9-4369-9F74-C8AE684630B8Q27300825-0A4D94D9-E7D3-48BB-BBA9-557A67D06738Q28281407-03E64889-A641-4E32-861A-56C4CA397A4DQ30479705-595BA460-034E-4CA9-BA7F-50E6609B3A90Q33387544-245865E8-B1D8-4D08-AC63-9BD0AAA36762Q33671166-C0B901A6-F73B-4DE0-AAF6-3AA3FD8278A3Q34237681-E7524945-8B0D-4D2B-A6F0-EF993B090CA9Q34661348-E445B984-1089-4D3E-A5A6-C3F033F29112Q34690050-D8AC81AC-EEDF-4DC8-8074-C7A5B7100FEEQ35161157-3F4C6009-DED3-4C0A-9163-DF65D078660FQ35171321-D4B85AF1-659E-4929-BE32-EFBE7DB519C4Q35608913-1C69D96F-6BB5-4ABE-8FE9-E67F7CB5207AQ36737979-134E4A8C-433B-4584-8618-B5046FE554A2Q36779955-5F3B43F0-4BEE-41A3-9738-9EDFCA097DE9Q36860205-7F7920ED-5D47-4B41-9FCB-E1735212C53CQ36979174-4BDD4AA8-797D-4C93-94DD-A08A64624FDEQ37654878-BD040734-727B-46A7-B82E-6B93B8CBB848Q37777007-B7025D90-A848-4BAE-8785-C95CFA67BDF1Q38114044-39D4CC1A-7742-4CF9-9894-C58D399C1BCAQ38660493-B0C91258-60DF-45EA-BA3C-8C2E87BEA665Q38781285-1348E1C7-0869-4F6B-A85F-AC91C1461992Q42374304-24E64E69-A083-4BFB-9CD2-F8AB6678BAA3Q43250319-51FAFAB2-12DA-4DF8-9D1B-D2940AA0C52FQ48460240-0AC8A92D-99C8-4997-905E-619F66A3FC37Q50679392-FAFDD248-420F-4E7C-A0F1-B612778C91DE
P2860
Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pregnancy outcomes following e ...... a-analysis of clinical trials.
@ast
Pregnancy outcomes following e ...... a-analysis of clinical trials.
@en
type
label
Pregnancy outcomes following e ...... a-analysis of clinical trials.
@ast
Pregnancy outcomes following e ...... a-analysis of clinical trials.
@en
prefLabel
Pregnancy outcomes following e ...... a-analysis of clinical trials.
@ast
Pregnancy outcomes following e ...... a-analysis of clinical trials.
@en
P31
P1476
Pregnancy outcomes following e ...... a-analysis of clinical trials.
@en
P2093
Shekoufeh Nikfar
P304
P356
10.1016/J.REPROTOX.2006.03.019
P577
2006-05-23T00:00:00Z